linezolid and its Impurities

An antibacterial drug which is used for the treatment of infections caused by Gram-positive bacteria. Linezolid belongs to oxazolidinone class of medicines, which are are protein synthesis inhibitors. Linezolid stops the growth and reproduction of bacteria by disrupting translation of messenger RNA (mRNA) into proteins in the ribosome. Reference standards of Linezolid API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 9 results for linezolid Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 12 0191055

(S)-N-Benzyl-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)nitrous amide

(S)-N-Benzyl-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)nitrous amide


  • Catalogue No.:PA 12 0191055

  • CAS :

    NA

  • Molecular Formula : C21H23FN4O4

  • Molecular Weight : 414.44

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191056

4-(2-Fluoro-5-nitrophenyl)morpholine

4-(2-Fluoro-5-nitrophenyl)morpholine


  • Catalogue No.:PA 12 0191056

  • CAS :

    1233093-70-3

  • Molecular Formula : C10H11FN2O3

  • Molecular Weight : 226.21

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191057

(S)-N-((3-(4-Fluoro-3-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide

(S)-N-((3-(4-Fluoro-3-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide


  • Catalogue No.:PA 12 0191057

  • CAS :

    1644566-11-9

  • Molecular Formula : C16H20FN3O4

  • Molecular Weight : 337.35

Drug Reference Standards & Impurity Synthesis in India
PA BSC 01912822

Linezolid Desacetamide Hydroxy Impurity (BSC)

Linezolid Desacetamide Hydroxy Impurity


  • Catalogue No.:PA BSC 01912822

  • CAS :

    168828-82-8

  • Molecular Formula : C14H17FN2O4

  • Molecular Weight : 296.3

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191058

(S)-N-(3-Amino-2-hydroxypropyl)-N-(3-fluoro-4-morpholinophenyl)acetamide

(S)-N-(3-Amino-2-hydroxypropyl)-N-(3-fluoro-4-morpholinophenyl)acetamide


  • Catalogue No.:PA 12 0191058

  • CAS :

    333753-69-8

  • Molecular Formula : C15H22FN3O3

  • Molecular Weight : 311.36

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191059

(R)-1-((tert-Butyldimethylsilyl)oxy)-3-chloropropan-2-ol

(R)-1-((tert-Butyldimethylsilyl)oxy)-3-chloropropan-2-ol


  • Catalogue No.:PA 12 0191059

  • CAS :

    136984-26-4

  • Molecular Formula : C9H21ClO2Si

  • Molecular Weight : 224.8

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191060

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)propionamide

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)propionamide


  • Catalogue No.:PA 12 0191060

  • CAS :

    216869-17-9

  • Molecular Formula : C17H22FN3O4

  • Molecular Weight : 351.38

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191061

(S)-N1-((3-(3-Fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)-N2-methylphthalamide

(S)-N1-((3-(3-Fluoro-4-Morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)-N2-methylphthalamide


  • Catalogue No.:PA 12 0191061

  • CAS :

    NA

  • Molecular Formula : C23H25FN4O5

  • Molecular Weight : 456.47

Drug Reference Standards & Impurity Synthesis in India
PA 12 0191062

(R)-N-(3-Chloro-2-hydroxypropyl)-N-(3-fluoro-4-morpholinophenyl)nitrous amide

(R)-N-(3-Chloro-2-hydroxypropyl)-N-(3-fluoro-4-morpholinophenyl)nitrous amide


  • Catalogue No.:PA 12 0191062

  • CAS :

    NA

  • Molecular Formula : C13H17ClFN3O3

  • Molecular Weight : 317.75

pharmaffiliates